Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS D FLORES

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1285608216
CMS profile
58443
Location
SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,737.70

161 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,537.76 159
Education $199.94 2

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS D FLORES

NPI 1285608216 · CMS profile ID 58443

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

SAN JUAN, PR

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1285608216?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS D FLORES, NPI 1285608216, CMS profile ID 58443. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1285608216?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). LUIS D FLORES, NPI 1285608216, CMS profile ID 58443. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1285608216?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
LUIS D FLORES, NPI 1285608216, CMS profile ID 58443, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 161 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1285608216?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

161 matching records · $3,737.70 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 161 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 161.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme LLC $19.6205/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238317368 CMS
Janssen Pharmaceuticals, Inc $25.0005/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174864474 CMS
Janssen Pharmaceuticals, Inc $25.0005/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174862699 CMS
Amgen Inc. $21.7605/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228617947 CMS
Merck Sharp & Dohme LLC $19.6205/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238181789 CMS
Novartis Pharmaceuticals Corporation $19.9705/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200288066 CMS
SOBI, INC $21.8504/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240241896 CMS
Janssen Pharmaceuticals, Inc $20.6804/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174864676 CMS
Merck Sharp & Dohme LLC $22.8304/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238314800 CMS
Janssen Pharmaceuticals, Inc $25.0004/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174867997 CMS
ABBVIE INC. $25.0004/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201865164 CMS
Novartis Pharmaceuticals Corporation $23.8304/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200288062 CMS
Genentech USA, Inc. $17.2104/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211538238 CMS
Janssen Pharmaceuticals, Inc $23.5404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174863701 CMS
Janssen Pharmaceuticals, Inc $18.3204/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174868472 CMS
AstraZeneca Pharmaceuticals LP $20.0003/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206608962 CMS
Alexion Pharmaceuticals, Inc. $30.0003/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202914698 CMS
E.R. Squibb & Sons, L.L.C. $20.9703/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943407 CMS
Amgen Inc. $13.8503/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227105238 CMS
E.R. Squibb & Sons, L.L.C. $19.8703/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943405 CMS
Incyte Corporation $20.0003/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226049585 CMS
TOLMAR, INC. $19.9803/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237009219 CMS
pharmaand GmbH $19.9803/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1182988660 CMS
Regeneron Healthcare Solutions, Inc. $23.3603/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212920694 CMS
E.R. Squibb & Sons, L.L.C. $23.8303/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943393 CMS
AstraZeneca Pharmaceuticals LP $22.0003/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206560243 CMS
Stemline Therapeutics Inc. $19.5403/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244098053 CMS
E.R. Squibb & Sons, L.L.C. $23.8303/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943385 CMS
Incyte Corporation $99.9503/06/2025 Education No dispute reported Delay: No
Change: NEW
06/30/2026 1226049687 CMS
Incyte Corporation $19.8003/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226071075 CMS
AstraZeneca Pharmaceuticals LP $22.0003/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206538970 CMS
PBG PUERTO RICO LLC $25.0002/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231367046 CMS
PBG PUERTO RICO LLC $25.6802/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231431204 CMS
GENZYME CORPORATION $23.5402/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233373118 CMS
Janssen Pharmaceuticals, Inc $23.4502/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174867145 CMS
AstraZeneca Pharmaceuticals LP $25.0002/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206994263 CMS
E.R. Squibb & Sons, L.L.C. $19.6602/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943379 CMS
Janssen Pharmaceuticals, Inc $23.6302/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174868519 CMS
Merck Sharp & Dohme LLC $19.6602/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238353734 CMS
Janssen Pharmaceuticals, Inc $25.0002/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174867038 CMS
E.R. Squibb & Sons, L.L.C. $30.0002/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943391 CMS
PBG PUERTO RICO LLC $16.1502/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231455182 CMS
Amgen Inc. $20.0002/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228617951 CMS
Janssen Pharmaceuticals, Inc $23.9002/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174867603 CMS
Merck Sharp & Dohme LLC $20.8302/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238041743 CMS
Janssen Pharmaceuticals, Inc $23.4502/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174866822 CMS
Janssen Pharmaceuticals, Inc $20.5001/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174862432 CMS
Novartis Pharmaceuticals Corporation $20.5101/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200288060 CMS
E.R. Squibb & Sons, L.L.C. $25.0001/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184943375 CMS
AstraZeneca Pharmaceuticals LP $20.0001/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207205972 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,169.58 172
PY2020 $2,754.21 154
PY2021 $3,569.71 176
PY2022 $3,685.85 175
PY2023 $3,622.30 164
PY2024 $4,365.17 155
PY2025 $3,737.70 161

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $106,193.28 6
PY2024 Principal investigator $204,213.22 5
PY2023 Principal investigator $461,107.01 7
PY2022 Principal investigator $781,199.32 8
PY2021 Principal investigator $501,782.12 6
PY2020 Principal investigator $172,794.47 67

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $7,019.47 12/31/2025 Non-covered Recipient Entity
Puerto Rico Medical Research Center LLC
A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 with Pembrolizumab MK-3475 in Combination with Transarterial Chemoembolization TACE Versus TACE in P No dispute reported 06/30/2026 1232938260
Principal investigator 1 Merck Sharp & Dohme LLC $69,517.06 11/18/2025 Non-covered Recipient Entity
Puerto Rico Medical Research Center LLC
A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 with Pembrolizumab MK-3475 in Combination with Transarterial Chemoembolization TACE Versus TACE in P No dispute reported 06/30/2026 1232938258
Principal investigator 1 Merck Sharp & Dohme LLC $351.48 08/31/2025 Non-covered Recipient Entity
Puerto Rico Medical Research Center LLC
A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 with Pembrolizumab MK-3475 in Combination with Transarterial Chemoembolization TACE Versus TACE in P No dispute reported 06/30/2026 1232938262
Principal investigator 1 AstraZeneca Pharmaceuticals LP $1,316.04 04/23/2025 Non-covered Recipient Entity
LONG ISLAND REGIONAL ARTHRITIS AND OSTEOPOROSIS CARE, PC
A Phase III Randomized Open-Label Sponsor-Blinded Multicenter Study of Durvalumab in Combination with Tremelimumab Lenvatinib Given Concurrently with Transarterial Chemoembolization (TACE) Compared to TACE Alone in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-3) No dispute reported 06/30/2026 1185550785
Principal investigator 1 AstraZeneca Pharmaceuticals LP $627.02 03/19/2025 Non-covered Recipient Entity
PUERTO RICO CONSORTIUM FOR CLINICAL INVESTIGATION
A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) No dispute reported 06/30/2026 1185550781
Principal investigator 1 AstraZeneca Pharmaceuticals LP $27,362.21 02/26/2025 Non-covered Recipient Entity
PUERTO RICO CONSORTIUM FOR CLINICAL INVESTIGATION
A Phase III Randomized Open-Label Sponsor-Blinded Multicenter Study of Durvalumab in Combination with Tremelimumab Lenvatinib Given Concurrently with Transarterial Chemoembolization (TACE) Compared to TACE Alone in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-3) No dispute reported 06/30/2026 1185550783